Immunotherapies in sarcoma: Updates and future perspectives
about
Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis.Managing sarcoma: where have we come from and where are we going?Current status of proteomics of soft tissue sarcomas.Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.
P2860
Immunotherapies in sarcoma: Updates and future perspectives
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapies in sarcoma: Updates and future perspectives
@en
Immunotherapies in sarcoma: Updates and future perspectives.
@nl
type
label
Immunotherapies in sarcoma: Updates and future perspectives
@en
Immunotherapies in sarcoma: Updates and future perspectives.
@nl
prefLabel
Immunotherapies in sarcoma: Updates and future perspectives
@en
Immunotherapies in sarcoma: Updates and future perspectives.
@nl
P2093
P2860
P356
P1476
Immunotherapies in sarcoma: Updates and future perspectives
@en
P2093
Elie El Rassy
Hampig Raphael Kourie
Marwan Ghosn
P2860
P304
P356
10.5306/WJCO.V8.I2.145
P577
2017-04-01T00:00:00Z